Clinical Trials Logo

Cognitive Symptoms clinical trials

View clinical trials related to Cognitive Symptoms.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02144688 Terminated - Cognitive Symptoms Clinical Trials

COMO: Cognition Study With HIV+ Patients (CTNPT 015)

COMO
Start date: June 2011
Phase: Phase 0
Study type: Interventional

The purpose of this study is to contribute evidence towards the potential to improve cognition in HIV+ individuals experiencing cognitive decline through personalized change in antiretroviral (ARV) medication. To that end, following a comprehensive evaluation to identify confounding clinical conditions, study participants will undergo a lumbar puncture to: (i) measure viral load (at 2 copies/ml); (ii) identify Cerebrospinal Fluid (CSF) genotype and tropism; and (iii) measure concentration of antiretroviral agents. When indicated from the CSF analysis, a personalized change in ARV will be implemented. Cognition will be measured in all at study entry and 6 months later.

NCT ID: NCT00134953 Terminated - Cognitive Symptoms Clinical Trials

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Start date: January 2003
Phase: Phase 3
Study type: Interventional

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment (MCI).